Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002417:Cattle; D002645:Chickens; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006589:Hexestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen / Q000378:metabolism; D014599:Uterus / Q000187:drug effects
D004965:Estrogen Antagonists; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D006589:Hexestrol; C033293:NSC 297170; C039150:1,1,2,2-tetramethyl-1,2-bis(4'-hydroxyphenyl)ethane